Childhood Pneumonia Clinical Trial
Official title:
A Clinical and Microbiological Study of Acute Respiratory Infections in Refugee Infants Living on the Thai-Burmese Border
This study will follow 1000 refugee infants from birth for two years. The aim of the study is to better understand why some children develop infections caused by the bacterium Streptococcus pneumoniae whilst others merely carry this organism asymptomatically at the back of the nose (in the nasopharynx). The investigators will also define which micro-organisms cause lower respiratory tract infections (e.g., pneumonia) in this population in order to implement appropriate interventions (e.g., vaccines). Infants will be reviewed monthly and a nasopharyngeal swab will be taken. A group of 250 mother-infant pairs will be studied in greater detail, to improve our understanding of the frequency and outcomes of nasopharyngeal carriage of Streptococcus pneumoniae. Monthly nasopharyngeal swabs will be collected from mothers and infants. The investigators will measure the infant immune response to Streptococcus pneumoniae carriage or disease by taking monthly blood samples. The investigators will make an assessment of the protective effect of antibodies acquired from the mother during pregnancy by taking blood from the mother and placenta at birth. An assessment of pneumococcal carriage in mothers will also be made to determine how frequently the bacterium is transmitted between family members. All lower respiratory tract infections will be documented, and the causative micro-organisms identified.
This project's central hypothesis is that acute lower respiratory infections (ALRI) are a
common and significant cause of morbidity and mortality in young children living in Maela
refugee camp on the Thai-Burmese border, and that this is reflective of the general
situation in the developing world. Therefore, we aim to define the incidence, aetiology, and
outcome of acute lower respiratory infections in this population. This will focus on
Streptococcus pneumoniae and the factors associated with colonisation and invasive disease.
Additional objectives are to:
1. Characterise the interaction between bacterial and viral pathogens and disease.
2. Examine the dynamics of pneumococcal nasopharyngeal carriage, including transmission of
strains between infants and their mothers.
3. Determine the effect of the non-pathogenic members of the nasopharyngeal flora on
colonisation with potential pathogens.
4. Examine the role of passively transferred maternal pneumococcal antibodies in
subsequent pneumococcal colonisation and disease in the infant.
5. Document the development of pneumococcal antibodies in the infants over time and
correlate these with pneumococcal carriage and infection episodes.
6. Determine the risk factors associated with respiratory infection.
7. Characterise the bacteria causing invasive non-respiratory infections.
8. Conduct surveillance for influenza and in particular avian influenza A (H5N1)
infection.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01345695 -
Bihar Evaluation of Social Franchising and Telemedicine
|
N/A | |
Completed |
NCT03784274 -
Pneumonia Policy Formation in Pakistan
|
||
Completed |
NCT03869099 -
Pneumonia Case Management Practices in Pakistan
|
||
Completed |
NCT03613636 -
Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)
|
||
Completed |
NCT00933049 -
Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months
|
Phase 3 | |
Completed |
NCT03959956 -
Improving Paediatric Pneumonia Diagnosis Using Digital Auscultation
|
||
Completed |
NCT03594279 -
Community Mobilization and Incentivization for Childhood Diarrhea and Pneumonia
|
N/A | |
Recruiting |
NCT03750747 -
Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services
|
N/A | |
Completed |
NCT04495361 -
Online Learning Portal on Under Five Pneumonia
|
N/A | |
Completed |
NCT04493047 -
mHealth for Pneumonia Prevention
|
N/A |